Overview
Deborah Stephens is a Hematologist and a Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Stephens is rated as an Elite provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Stephens is currently accepting new patients.
Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 66 articles and participated in 10 clinical trials in the study of Leukemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
Duke Health Integrated Practice Inc
Danielle Brander is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Brander is rated as an Elite provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Leukemia, and Bone Marrow Aspiration. Dr. Brander is currently accepting new patients.
University Of North Carolina At Chapel Hill
Joshua Zeidner is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Zeidner is rated as an Elite provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Zeidner is currently accepting new patients.
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)Dr. Stephens isElite. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- LeukemiaDr. Stephens isElite. Learn about Leukemia.
- Small Lymphocytic Lymphoma (SLL)
- Distinguished
- B-Cell LymphomaDr. Stephens isDistinguished. Learn about B-Cell Lymphoma.
- Follicular LymphomaDr. Stephens isDistinguished. Learn about Follicular Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Stephens isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Stephens isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Prolymphocytic LeukemiaDr. Stephens isDistinguished. Learn about Prolymphocytic Leukemia.
- Richter SyndromeDr. Stephens isDistinguished. Learn about Richter Syndrome.
- Advanced
- Bone Marrow AspirationDr. Stephens isAdvanced. Learn about Bone Marrow Aspiration.
- Classical Hodgkin LymphomaDr. Stephens isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Stephens isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Stephens isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Marginal Zone Lymphoma (MZL)Dr. Stephens isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Primary Lymphoma of the BrainDr. Stephens isAdvanced. Learn about Primary Lymphoma of the Brain.
- Experienced
- Acute Eosinophilic PneumoniaDr. Stephens isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Stephens isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Stephens isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Stephens isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaDr. Stephens isExperienced. Learn about Adult T-Cell Leukemia.

